Clinical Chemistry Market Growth Accelerates with Rising Chronic Disease Cases

The clinical chemistry market is entering a phase of significant expansion, with its size projected to increase from US$ 10.1 billion in 2026 to US$ 13.8 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.6%. This promising growth trajectory is largely driven by the rising prevalence of chronic diseases, innovations in diagnostic technologies, and the growing adoption of automated systems. With chronic conditions such as diabetes, cardiovascular diseases (CVDs), and kidney disorders on the rise, the demand for diagnostic testing, including routine chemistry panels, is expected to soar. The World Health Organization (WHO) has highlighted the global burden of CVDs, further underscoring the need for frequent biochemical tests to monitor patient health.